MAPT and Alzheimer disease: Several previous studies have shown that LAMP2A deficiency deteriorates tau pathologies in AD model mice,5, 8 whereas pathologic tau can interfere with the CMA pathway and compromise CMA‐mediated pathologic tau degradation.7, 9